J B Chemicals & Pharmaceuticals Ltd Share Price (JBCHEPHARM)

J B Chemicals & Pharmaceuticals Ltd Stock Gains Over 50% in Last Six Months - 13 Sep, 2023

J B Chemicals & Pharmaceuticals Ltd's stock has surged over 50% in the last six months, following a stock split announcement. The company's Q1FY24 results also showed promising growth with an increase in revenue and profit.

Private Equity Firms Own 54% of J B Chemicals & Pharmaceuticals - 12 Sep, 2023

KKR & Co. Inc. is the largest shareholder of J B Chemicals & Pharmaceuticals with a 54% stake, giving them significant control over the company's future. Institutions account for 25%, insiders less than 1%, and the general public holds 21%.

CFO Resignation at JB Chemicals and Pharmaceuticals - 08 Sep, 2023

Lakshay Kataria, Chief Financial Officer of JB Chemicals and Pharmaceuticals, has resigned due to personal reasons. His resignation will be effective from November 30, 2023.

J B Chemicals & Pharmaceuticals Fixes Record Date for Stock Split - 31 Aug, 2023

J.B. Chemicals and Pharmaceuticals has fixed September 18, 2023, as the record date for a 1:2 stock split, with each share being subdivided into two equity shares with a face value of ₹ 1 each.

JB Pharma Gets Clearance from USFDA for Generic Version of Sinequan - 24 Aug, 2023

JB Chemicals & Pharmaceuticals Ltd's subsidiary, JB Pharma, receives approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Doxepin Hydrochloride Capsules, allowing production of a generic version of Pfizer's Sinequan. Stock falls slightly due to technical pullback.

JB Chemicals Receives FDA Approval for Generic Drug - 23 Aug, 2023

JB Chemicals & Pharmaceuticals Ltd has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules, a generic version of Pfizer's Sinequan capsules used to treat mood disorders.

J B Chemicals & Pharmaceuticals CEO Divests Shares - 20 Aug, 2023

CEO Nikhil Chopra divested ₹40m worth of shares, reducing their holding by 50%. Insider selling leaves investors cautious despite the company's profitability and growth.

JB Chemicals & Pharmaceuticals Declares Dividend - 17 Aug, 2023

JB Chemicals & Pharmaceuticals Ltd has declared a dividend of Rs 9.25 per equity share with a face value of Rs 2, with the record date set as August 17.

JB Chemicals & Pharmaceuticals Announces Dividend - 16 Aug, 2023

JB Chemicals & Pharmaceuticals Ltd has announced a dividend of Rs 9.25 per equity share with a face value of Rs 2, with the record date set for August 17.

JB Chemicals & Pharmaceuticals Records Growth in Indian Pharma Market - 14 Aug, 2023

JB Chemicals and Pharmaceuticals saw a YoY growth of 8-11% in the Indian pharma market in July.

JB Chemicals & Pharmaceuticals Reports Strong Q1 Results - 10 Aug, 2023

JB Chemicals & Pharmaceuticals Ltd reports a strong Q1 FY24 with a 35% YoY increase in net profit and 14% growth in revenue. Gross margins also expanded by 270 bps.

JB Chemicals & Pharmaceuticals Reports Strong Q1 Results - 09 Aug, 2023

JB Chemicals & Pharmaceuticals Ltd reported a 35% YoY increase in Q1FY24 net profit to Rs 142 crore and a 14% YoY growth in revenue to Rs 896 crore. Domestic formulations business grew 17%, while international business crossed the Rs 400 crore mark for the first time.

J B Chemicals & Pharmaceuticals Increases Dividend, But Caution Advised - 03 Aug, 2023

J. B. Chemicals & Pharmaceuticals has announced an increase in dividend to ₹9.25, but with negative free cash flows and unstable dividend history, it may not be a good income stock.

JB Chemicals & Pharmaceuticals Reports Strong Exports Growth and Trading at Lifetime High - 12 Jul, 2023

JB Chemicals & Pharmaceuticals Ltd reports strong export growth to the U.S. for Q1 FY24 and trades at a lifetime high after breaking above an upwards-tiled channel with a positive MACD crossover.

JB Chemicals hits 5-year high after Jefferies initiates buy rating - 21 Jun, 2023

JB Chemicals & Pharmaceuticals achieves 5-year high after Jefferies initiates buy rating. Robust product portfolio, strong R&D capabilities, and strategic acquisitions fuel growth.

JB Chemicals surges to record high on Jefferies' bullish view - 20 Jun, 2023

Jefferies assigns a buy rating and a price target of Rs 2,680 per share for JB Chemicals, expecting it to outperform industry growth.